                         SEQUENCE LISTING

<110>  NARA, PETER  L
       TOBIN, GREG J
       LIN, GEORGE
 
<120>  IMMUNOGENIC INFLUENZA COMPOSITION

<130>  020812-02840001

<150>  US 61/030,255
<151>  2008-02-21

<160>  40    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Influenza Strain, Residues 140-146 of HA Immunodominant Site A

<400>  1

Lys Arg Arg Ser Asn Lys Ser 
1               5           


<210>  2
<211>  9
<212>  PRT
<213>  Influenza Strain, Residues 189-197 of HA Immunodominant Site B

<400>  2

Ser Asp Gln Ile Ser Leu Tyr Ala Gln 
1               5                   


<210>  3
<211>  4
<212>  PRT
<213>  Influenza strain, Peptide Sequence which Interacts with AA 158-161 of HA Immunodominant Site B

<400>  3

Lys Tyr Lys Tyr 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Infleunza Strain, Residues 79-82 of HA Immunodominant Site E

<400>  4

Phe Gln Asn Lys 
1               


<210>  5
<211>  45
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer for Mutagenesis of HA Immunodominant Site A

<400>  5
ggaacaagct ctgcttgcgg cggtttcttt agtagattga attgg                       45


<210>  6
<211>  45
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site A

<400>  6
ccaattcaat ctactaaaga aaccgccgca agcagagctt gttcc                       45


<210>  7
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-Containing AA Sequence at HA Immunodominant Site A

<400>  7

Gly Thr Ser Ser Ala Cys Gly Gly Phe Phe Ser Arg Leu Asn 
1               5                   10                  


<210>  8
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 1

<400>  8
caaatcagcc tatatgctaa tgcatcagga agaatcac                               38


<210>  9
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 1

<400>  9
gtgattcttc ctgatgcatt agcatatagg ctgatttg                               38


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-1-Containing AA Sequence at HA Immunodominant Site B

<400>  10

Gln Ile Ser Leu Tyr Ala Asn Ala Ser Gly Arg Ile 
1               5                   10          


<210>  11
<211>  47
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 2

<400>  11
caccacccgg ttacggacaa tgacacaatc agcctatatg ctcaagc                     47


<210>  12
<211>  47
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 2

<400>  12
gcttgagcat ataggctgat tgtgtcattg tccgtaaccg ggtggtg                     47


<210>  13
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-2-Containing AA Sequence at HA Immunodominant Site B

<400>  13

His His Pro Val Thr Asp Asn Asp Thr Ile Ser Leu Tyr Ala Gln 
1               5                   10                  15  


<210>  14
<211>  43
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 3

<400>  14
cggacagtga ccaaatcaat ctatctgctc aagcatcagg aag                         43


<210>  15
<211>  43
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 3

<400>  15
cttcctgatg cttgagcaga tagattgatt tggtcactgt ccg                         43


<210>  16
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-3-Containing AA Sequence at HA Immunodominant Site B

<400>  16

Asp Ser Asp Gln Ile Asn Leu Ser Ala Gln Ala Ser Gly 
1               5                   10              


<210>  17
<211>  48
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 4

<400>  17
gaattggttg acccacttaa attacacata cccagcattg aacgtgac                    48


<210>  18
<211>  48
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 4

<400>  18
gtcacgttca atgctgggta tgtgtaattt aagtgggtca accaattc                    48


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-4-Containing AA Sequence at HA Immunodominant Site B

<400>  19

Asn Trp Leu Thr His Leu Asn Tyr Thr Tyr Pro Ala Leu Asn Val 
1               5                   10                  15  


<210>  20
<211>  52
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 5

<400>  20
gaattggttg acccacttaa aaaacaaaac cccagcattg aacgtgacta tg               52


<210>  21
<211>  52
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site B, Mutein 5

<400>  21
catagtcacg ttcaatgctg gggttttgtt ttttaagtgg gtcaaccaat tc               52


<210>  22
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-5-Containing AA Sequence at HA Immunodominant Site B

<400>  22

Asn Trp Leu Thr His Leu Lys Asn Lys Thr Pro Ala Leu Asn Val Thr 
1               5                   10                  15      


Met 
    


<210>  23
<211>  46
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site C

<400>  23
gatcagatgc acccattggc aattgcagtt ctgaatgcat cactcc                      46


<210>  24
<211>  46
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site C

<400>  24
ggagtgatgc attcagaact gcaattgcca atgggtgcat ctgatc                      46


<210>  25
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-Containing AA Sequence at HA Immunodominant Site C

<400>  25

Ser Asp Ala Pro Ile Gly Asn Cys Ser Ser Glu Cys Ile Thr 
1               5                   10                  


<210>  26
<211>  44
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site D

<400>  26
ctatatgctc aagcatcagg aaatatcaca gtctctacca aaag                        44


<210>  27
<211>  44
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site D

<400>  27
cttttggtag agactgtgat atttcctgat gcttgagcat atag                        44


<210>  28
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-Containing AA Sequence at HA Immunodominant Site D

<400>  28

Leu Tyr Ala Gln Ala Ser Gly Asn Ile Thr Val Ser Thr Lys Arg Ser 
1               5                   10                  15      


<210>  29
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site E

<400>  29
gatggcttcc aaaataagac atgggacctt tttgttgaac                             40


<210>  30
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer For Mutagenesis of HA Immunodominant Site E

<400>  30
gttcaacaaa aaggtcccat gtcttatttt ggaagccatc                             40


<210>  31
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-Containing AA Sequence at HA Immunodominant Site E

<400>  31

Asp Gly Phe Gln Asn Lys Thr Trp Asp Leu Phe Val Glu 
1               5                   10              


<210>  32
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HA Sequencing Primer, S1

<400>  32
cagtcctcat cagatccttg                                                   20


<210>  33
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HA Sequencing Primer, S2

<400>  33
ggtaagggat atctccagca g                                                 21


<210>  34
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HA Sequencing Primer, S3

<400>  34
cgcgattgcg ccaaatatgc c                                                 21


<210>  35
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein of HA Immunodominant Site B Interacting Peptide

<400>  35

Ala Tyr Lys Tyr 
1               


<210>  36
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Immunodominant Site B-Mutein AA Sequence

<400>  36

Ser Ala Gln Ile 
1               


<210>  37
<211>  9
<212>  PRT
<213>  Influenza Strain, T-Cell CD4 Epitope

<400>  37

Leu Tyr Ile Trp Gly Val His His Pro 
1               5                   


<210>  38
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-Containing AA Sequence of T-Cell CD4 Epitope, Y

<400>  38

Val Tyr Ile Trp 
1               


<210>  39
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-Containing AA Sequence of T-Cell CD4 Epitope, T

<400>  39

Val Thr Ile Trp 
1               


<210>  40
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutein-Containing AA Sequence of T-Cell CD4 Epitope, I

<400>  40

Ile His Ala Gly 
1               


